skip to main content
US FlagAn official website of the United States government
dot gov icon
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
https lock icon
Secure .gov websites use HTTPS
A lock ( lock ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Explore Research Products in the PAR
It may take a few hours for recently added research products to appear in PAR search results.


Title: Translocator Protein in Brain Tissue and Neurodegeneration
Neurodegenerative disorders, such as Alzheimer's Disease, effect over 50 million Americans a year, and despite the high prevalence, the pathogenesis of these diseases remains unclear. However, researchers have noticed a dramatic up-regulation of a protein called translocator protein (TSPO) under neurodegenerative and neuro-inflammatory conditions. While TSPO expression is prevalent in the brain, it is still unclear as to what exact types of cells TSPO is expressed in, and what mechanisms result in increased expression. Regulating the expression or function of TSPO is believed to have an impact on neurodegenerative processes, but definitive evidence of this is also limited. To advance our understanding we will examine what cells TSPO is expressed in, and reveal what effects TSPO agonists and antagonists will have on brain activity= patterns using electroencephalography. Some research has found that certain TSPO ligands have potential to be therapeutic agents for neurodegeneration, neuro-inflammation and neurotrauma. Therefore, localization of TSPO in brain tissue and investigation of the mechanism by which it becomes activated, may allow for the development of novel treatments for neurodegenerative issues such as Alzheimer's.  more » « less
Award ID(s):
1757316
PAR ID:
10218337
Author(s) / Creator(s):
Date Published:
Journal Name:
Journal of health disparities research and practice
Volume:
12
Issue:
STEP-UP
ISSN:
2166-5222
Page Range / eLocation ID:
65
Format(s):
Medium: X
Sponsoring Org:
National Science Foundation
More Like this
  1. ; ; (, Abstracts - Society for Neuroscience)
    Expansion mutation within polyglutamine (polyQ) tract proteins is known to underlie a number of severe neurodegenerative disorders such as Huntington’s Disease and Spinocerebellar Ataxia. Using a bioinformatics approach, we have identi􀃕ed a novel protein, FAM171B, that contains a stretch of 14 consecutive glutamines. Using in situ hybridization and immunohistochemistry experiments, our data strongly suggests that FAM171B is widely expressed in the brain with abundant expression in the hippocampus, cortex, and cerebellum. To begin elucidating FAM171B sub-cellular location we are using confocal 􀃖uorescence imaging of GFP-fusion tagged FAM171B and anti-FAM171B antibodies in vitro. Our 􀃕ndings indicate that FAM171B displays a punctate/vesicular staining pattern throughout the cytoplasm of human glioblastoma tissue culture cells and primary mouse cortical neurons. FAM171B localization is particularly enriched in the peri-nuclear region and adjacent to the plasma membrane. Current studies are utilizing organelle speci􀃕c markers to verify sub-cellular locale and live-cell imaging to assay whether FAM171B may tra􀃞c between intracellular compartments. 
    more » « less
  2. ; ; ; ; ; ; ; ; (, Biomaterials Science)
    Alzheimer's disease (AD) is a progressive and neurodegenerative disease, predominantly causing dementia. Despite increasing clinical evidence suggesting the involvement of peripheral immune cells such as monocytes in AD pathology, the dynamic penetration and infiltration of monocytes crossing blood–brain barrier (BBB) and inducing neuroinflammation is largely understudied in an AD brain. Herein, we engineer BBB-like microphysiological system (BBB-MPS) models for recapitulating the dynamic penetration and infiltration of monocytes in an AD patient's brain. Each BBB-MPS model can be engineered by integrating a functional BBB-like structure on a human cortical organoid using a 3D-printed device within a well of a plate. By coculturing these BBB-MPS models with monocytes from AD patients and age-matched healthy donors, we found that AD monocytes exhibit significantly greater BBB penetration and brain infiltration compared to age-matched control monocytes. Moreover, we also tested the interventions including Minocycline and Bindarit, and found they can effectively inhibit AD monocyte infiltration, subsequently reducing neuroinflammation and neuronal apoptosis. We believe these scalable and user-friendly BBB-MPS models may hold promising potential in modeling and advancing therapeutics for neurodegenerative and neuroinflammatory diseases. 
    more » « less
  3. ; ; ; ; ; ; (, eLife)
    The central complex (CX) plays a key role in many higher-order functions of the insect brain including navigation and activity regulation. Genetic tools for manipulating individual cell types, and knowledge of what neurotransmitters and neuromodulators they express, will be required to gain mechanistic understanding of how these functions are implemented. We generated and characterized split-GAL4 driver lines that express in individual or small subsets of about half of CX cell types. We surveyed neuropeptide and neuropeptide receptor expression in the central brain using fluorescent in situ hybridization. About half of the neuropeptides we examined were expressed in only a few cells, while the rest were expressed in dozens to hundreds of cells. Neuropeptide receptors were expressed more broadly and at lower levels. Using our GAL4 drivers to mark individual cell types, we found that 51 of the 85 CX cell types we examined expressed at least one neuropeptide and 21 expressed multiple neuropeptides. Surprisingly, all co-expressed a small molecule neurotransmitter. Finally, we used our driver lines to identify CX cell types whose activation affects sleep, and identified other central brain cell types that link the circadian clock to the CX. The well-characterized genetic tools and information on neuropeptide and neurotransmitter expression we provide should enhance studies of the CX. 
    more » « less
  4. ; ; ; ; ; (, Biometrics)
    Abstract Alzheimer's disease is the most common neurodegenerative disease. The aim of this study is to infer structural changes in brain connectivity resulting from disease progression using cortical thickness measurements from a cohort of participants who were either healthy control, or with mild cognitive impairment, or Alzheimer's disease patients. For this purpose, we develop a novel approach for inference of multiple networks with related edge values across groups. Specifically, we infer a Gaussian graphical model for each group within a joint framework, where we rely on Bayesian hierarchical priors to link the precision matrix entries across groups. Our proposal differs from existing approaches in that it flexibly learns which groups have the most similar edge values, and accounts for the strength of connection (rather than only edge presence or absence) when sharing information across groups. Our results identify key alterations in structural connectivity that may reflect disruptions to the healthy brain, such as decreased connectivity within the occipital lobe with increasing disease severity. We also illustrate the proposed method through simulations, where we demonstrate its performance in structure learning and precision matrix estimation with respect to alternative approaches. 
    more » « less
  5. ; ; ; (, Frontiers in Cellular Neuroscience)
    AMPA receptors (AMPARs) mediate the majority of fast excitatory transmission in the brain. Regulation of AMPAR levels at synapses controls synaptic strength and underlies information storage and processing. Many proteins interact with the intracellular domain of AMPARs to regulate their trafficking and synaptic clustering. However, a growing number of extracellular factors important for glutamatergic synapse development, maturation and function have emerged that can also regulate synaptic AMPAR levels. This mini-review highlights extracellular protein factors that regulate AMPAR trafficking to control synapse development and plasticity. Some of these factors regulate AMPAR clustering and mobility by interacting with the extracellular N-terminal domain of AMPARs whereas others regulate AMPAR trafficking indirectly via their respective signaling receptors. While several of these factors are secreted from neurons, others are released from non-neuronal cells such as glia and muscle. Although it is apparent that secreted factors can act locally on neurons near their sites of release to coordinate individual synapses, it is less clear if they can diffuse over longer ranges to coordinate related synapses within a circuit or region of the brain. Given that there are hundreds of factors that can be secreted from neuronal and non-neuronal cells, it will not be surprising if more extracellular factors that modulate AMPARs and glutamatergic synapses are discovered. Many open questions remain including where and when the factors are expressed, what regulates their secretion from different cell types, what controls their diffusion, stability, and range of action, and how their cognate receptors influence intracellular signaling to control AMPAR trafficking. 
    more » « less
  • Citation Formats
  • MLA
  • APA
  • Chicago
  • BibTeX
  • Save / Share this Record
  • Send to Email